Unassociated Document
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act 1934
Date of
Report (date of earliest event reported): September 29,
2009
JIANGBO
PHARMACEUTICALS, INC.
(Exact
name of registrant as specified in charter)
Florida
(State or
other jurisdiction of incorporation)
333-86347
|
65-1130026
|
(Commission File
Number)
|
(IRS Employer Identification
No.)
|
Middle
Section, Longmao Street, Area A, Laiyang Waixiangxing Industrial
Park
|
Laiyang
City, Yantai, Shandong Province, People’s Republic of China
26520
|
(Address
of principal executive offices and zip code)
(0086)535-7282997
(Registrant's
telephone number including area code)
GENESIS
PHARMACEUTICALS ENTERPRISES, INC.
(Registrant's
former name or former address, if changed since last report)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of registrant under any of the following
provisions:
o Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o Soliciting
material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR
240.14a-12(b))
o Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item
2.02
|
Results
of Operations and Financial
Condition.
|
On
September 29, 2009, Jiangbo Pharmaceuticals, Inc. (the “Company”) issued a
press release announcing its operating results for the fourth quarter and fiscal
year ended June 30, 2009. A copy of the press release is attached hereto as
Exhibit 99.1.
Item
9.01 Financial Statements
and Exhibits.
Exhibit No.
|
Description
|
|
|
99.1
|
Press
Release dated September 29,
2009.
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
JIANGBO
PHARMACEUTICALS, INC. |
|
|
|
|
|
|
By:
|
/s/ Cao
Wubo |
|
|
Name:
|
Cao
Wubo |
|
|
Title:
|
Chief
Executive Officer |
|
|
|
|
|
Dated:
October 1, 2009